The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Role for PPARγ in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockouts
Abstract
Peroxisome proliferator‐activated receptor (PPAR) γ is a nuclear receptor central to glucose and lipid homeostasis. PPARγ role in nonalcoholic fatty liver disease is controversial because PPARγ over‐expression is a general property of steatotic livers, but its activation by thiazolidinediones reduces hepatic steatosis. Here, we investigated hepatic PPARγ function by using Cre‐ lox P technology to generate hepatocyte (PPARγ Δhep )‐ and macrophage (PPARγ Δmac )‐specific PPARγ‐knockout mice. Targeted deletion of PPARγ in hepatocytes, and to a lesser extent in macrophages, protected mice against high‐fat diet‐induced hepatic steatosis. Down‐regulated expression of genes involved in lipogenesis (SCD1, SREBP‐1c, and ACC), lipid transport (CD36/FAT, L‐FABP, and MTP), and β‐oxidation (PPARα and ACO) was observed in PPARγ Δhep mice. Moreover, PPARγ Δhep mice showed improved glucose tolerance and reduced PEPCK expression without changes in Pcx, Fbp1, and G6Pc expression and CREB and JNK phosphorylation. In precision‐cut liver slices (PCLSs) and hepatocytes, rosiglitazone either alone or in combination with oleic acid increased triglyceride accumulation, an effect that was blocked by the PPARγ antagonist biphenol A diglycidyl ether (BADGE). PCLSs and hepatocytes from PPARγ Δhep mice showed blunted responses to rosiglitazone and oleic acid, whereas the response to these compounds remained intact in PCLSs from PPARγ Δmac mice. Collectively, these findings establish PPARγ expression in hepatocytes as a prosteatotic factor in fatty liver disease.—Morán‐Salvador, E., López‐Parra, M., García‐Alonso, V., Titos, E., Martínez‐Clemente, M., González‐Périz, A., López‐Vicario, C., Barak, Y., Arroyo, V., Clària, J. Role for PPARγ in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockouts. FASEB J. 25, 2538–2550 (2011). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
Conditional gene targeting in macrophages and granulocytes using LysMcre mice
Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R., & Förster, I. (1999) · Transgenic Research · doi:10.1023/a:1008942828960 · Cited by 2,098
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
Roles of PPARs in health and disease
Kersten, S., Desvergne, B., & Wahli, W. (2000) · Nature · doi:10.1038/35013000 · Cited by 1,956 · cited 1×
“Serum insulin and free fatty acid (FFA) levels were determined using the Ultrasensitive Mouse Insulin ELISA kit (Mercodia, Uppsala, Sweden) and the HR Series NEFA-HR(2) kit (Wako Chemicals, Richmond, VA, USA), respectively.”
MethodPostic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., & Magnuson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.305 · Cited by 1,302
He, W., Barak, Y., Hevener, A., Olson, P., Liao, D., Le, J., Nelson, M., Ong, E., Olefsky, J. M., & Evans, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536828100 · Cited by 976
Self-citationGavrilova, O., Haluzik, M., Matsusue, K., Cutson, J. J., Johnson, L., Dietz, K. R., Nicol, C. J., Vinson, C., Gonzalez, F. J., & Reitman, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300043200 · Cited by 707
Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
Vidal-Puig, A., Jimenez-Liñan, M., Lowell, B. B., Hamann, A., Hu, E., Spiegelman, B., Flier, J. S., & Moller, D. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118703 · Cited by 655
Ratziu, V., Giral, P., Jacqueminet, S., Charlotte, F., Hartemann–Heurtier, A., Serfaty, L., Podevin, P., Lacorte, J., Bernhardt, C., Bruckert, E., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.078 · Cited by 625 · cited 1×
“Finally, administration of TZDs improves hepatic steatosis in patients with nonalcoholic fatty liver disease (NAFLD), possibly by its primary insulin-sensitizing effect on adipose tissue (16, 17).”
BackgroundYu, S., Matsusue, K., Kashireddy, P., Cao, W.-Q., Yeldandi, V., Yeldandi, A. V., Rao, M. S., Gonzalez, F. J., & Reddy, J. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210062200 · Cited by 619
Matsusue, K., Haluzik, M., Lambert, G., Yim, S.-H., Gavrilova, O., Ward, J. M., Brewer, B., Reitman, M. L., & Gonzalez, F. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317223 · Cited by 585
Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists
Olefsky, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10843 · Cited by 537
Huang, W., Metlakunta, A., Dedousis, N., Zhang, P., Sipula, I., Dube, J. J., Scott, D. K., & O'Doherty, R. M. (2010) · Diabetes · doi:10.2337/db09-0016 · Cited by 520
Muscle-specific Pparg deletion causes insulin resistance
Hevener, A. L., He, W., Barak, Y., Le, J., Bandyopadhyay, G., Olson, P., Wilkes, J., Evans, R. M., & Olefsky, J. (2003) · Nature Medicine · doi:10.1038/nm956 · Cited by 492
Self-citationMechanisms of Disease Progression in Nonalcoholic Fatty Liver Disease
Jou, J., Choi, S., & Diehl, A. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091981 · Cited by 482
Hevener, A. L., Olefsky, J. M., Reichart, D., Nguyen, M. T. A., Bandyopadyhay, G., Leung, H.-Y., Watt, M. J., Benner, C., Febbraio, M. A., Nguyen, A.-K., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31561 · Cited by 459
Stienstra, R., Saudale, F., Duval, C., Keshtkar, S., Groener, J. E. M., van Rooijen, N., Staels, B., Kersten, S., & Müller, M. (2010) · Hepatology · doi:10.1002/hep.23337 · Cited by 452
Histopathology of nonalcoholic fatty liver disease
Brunt, E. M. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i42.5286 · Cited by 449
Norris, A. W., Chen, L., Fisher, S. J., Szanto, I., Ristow, M., Jozsi, A. C., Hirshman, M. F., Rosen, E. D., Goodyear, L. J., Gonzalez, F. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17305 · Cited by 417
Marra, F., Efsen, E., Romanelli, R. G., Caligiuri, A., Pastacaldi, S., Batignani, G., Bonacchi, A., Caporale, R., Laffi, G., Pinzani, M., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.9365 · Cited by 409
PPARγ2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes
Schadinger, S. E., Bucher, N. L. R., Schreiber, B. M., & Farmer, S. R. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00513.2004 · Cited by 376
Ratziu, V., Charlotte, F., Bernhardt, C., Giral, P., Halbron, M., LeNaour, G., Hartmann-Heurtier, A., Bruckert, E., & Poynard, T. (2010) · Hepatology · doi:10.1002/hep.23270 · Cited by 366
Memon, R. A., Tecott, L. H., Nonogaki, K., Beigneux, A., Moser, A. H., Grunfeld, C., & Feingold, K. R. (2000) · Endocrinology · doi:10.1210/endo.141.11.7771 · Cited by 302
Kupffer cell activation is a causal factor for hepatic insulin resistance
Lanthier, N., Molendi-Coste, O., Horsmans, Y., van Rooijen, N., Cani, P. D., & Leclercq, I. A. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00391.2009 · Cited by 257
PPARγ activation in adipocytes is sufficient for systemic insulin sensitization
Sugii, S., Olson, P., Sears, D. D., Saberi, M., Atkins, A. R., Barish, G. D., Hong, S.-H., Castro, G. L., Yin, Y.-Q., Nelson, M. C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912487106 · Cited by 255
Physiology and pathophysiology of liver inflammation, damage and repair.
Ramadori, G. P., Moriconi, F., Malik, I. A., & Dudás, J. (2008) · PubMed · Cited by 183
Bedoucha, M., Atzpodien, E., & Boelsterli, U. A. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00066-6 · Cited by 169
Zhang, Y.-L., Hernandez-Ono, A., Siri, P., Weisberg, S., Conlon, D., Graham, M. J., Crooke, R. M., Huang, L.-S., & Ginsberg, H. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604709200 · Cited by 147
Planagumà, A., Clària, J., Miquel, R., López‐Parra, M., Titos, E., Masferrer, J. L., Arroyo, V., & Rodé, J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2753fje · Cited by 144
Self-citationRahimian, R., Masih‐Khan, E., Lo, M., van Breemen, C., McManus, B. M., & Dubé, G. P. (2001) · Molecular and Cellular Biochemistry · doi:10.1023/a:1011927113563 · Cited by 127
Abnormalities of Lipid Metabolism in Nonalcoholic Fatty Liver Disease
Cheung, O., & Sanyal, A. J. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091979 · Cited by 127
Edvardsson, U., Bergström, M. F., Alexandersson, M., Bamberg, K., Ljung, B., & Dahllöf, B. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33479-9 · Cited by 124
Martínez‐Clemente, M., Ferré, N., González‐Périz, A., López‐Parra, M., Horrillo, R., Titos, E., Morán‐Salvador, E., Miquel, R., Arroyo, V., Funk, C. D., et al. (2009) · Hepatology · doi:10.1002/hep.23463 · Cited by 114
Self-citationEnomoto, N., Takei, Y., Hirose, M., Konno, A., Shibuya, T., Matsuyama, S., Suzuki, S., Ikejima, K., & Sato, N. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047217 · Cited by 99
Clementi, A. H., Gaudy, A. M., van Rooijen, N., Pierce, R. H., & Mooney, R. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.007 · Cited by 96
Yu, J. Q., Zhang, S., Chu, E. S., Go, M. Y. Y., Lau, R. H. Y., Zhao, J., Wu, C., Tong, L., Zhao, J., Poon, T. C. W., et al. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.02.006 · Cited by 84
An in vitro method of alcoholic liver injury using precision-cut liver slices from rats
Klassen, L. W., Thiele, G. M., Duryee, M. J., Schaffert, C. S., DeVeney, A. L., Hunter, C. D., Olinga, P., & Tuma, D. J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.05.012 · Cited by 49
Genetic Manipulations of PPARs: Effects on Obesity and Metabolic Disease
Barak, Y., & Kim, S. (2007) · PPAR Research · doi:10.1155/2007/12781 · Cited by 45
Self-citationAcetaldehyde Inhibits PPARγ via H2O2-Mediated c-Abl Activation in Human Hepatic Stellate Cells
Ceni, E., Crabb, D. W., Foschi, M., Mello, T., Tarocchi, M., Patussi, V., Moraldi, L., Moretti, R., Milani, S., Surrenti, C., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.009 · Cited by 42
Fat paradox of steatohepatitis
Tsukamoto, H., She, H., Hazra, S., Cheng, J. H., & Wang, J. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05294.x · Cited by 38
Insulin and oleic acid increase PPARγ2 expression in cultured mouse hepatocytes
Edvardsson, U., Ljungberg, A., & Oscarsson, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.008 · Cited by 29
Cited by
Energy Metabolism in the Liver
Rui, L. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130024 · Cited by 1,953
PPARs in Obesity-Induced T2DM, Dyslipidaemia and NAFLD
Gross, B., Pawlak, M., Lefebvre, P., & Staels, B. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.135 · Cited by 778
PPARs at the crossroads of lipid signaling and inflammation
Wahli, W., & Michalik, L. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.05.001 · Cited by 675
PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice
Wang, Y., Nakajima, T., Gonzalez, F. J., & Tanaka, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062061 · Cited by 540
PPARs: Fatty acid sensors controlling metabolism
Poulsen, L. L. C., Siersbæk, M., & Mandrup, S. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.01.003 · Cited by 510
Metadata
- Authors
- Morán‐Salvador, E., López‐Parra, M., García‐Alonso, V., Titos, E., Martínez‐Clemente, M., González‐Périz, A., López‐Vicario, C., Barak, Y., Arroyo, V., & Clària, J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2011-04-19
- Volume
- 25
- Issue
- 8
- Pages
- 2538-2550
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2162943945
- Cited by
- 389
- References
- 41
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.